Hikma Pharmaceuticals
Hikma Pharmaceuticals is a fast growing multinational group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed products.
Hikma operates through three businesses: "Branded", "Injectables" and "Generics", based principally in the Middle East and North Africa ("MENA"), where it is a market leader, the United States and Europe.
In 2014, Hikma achieved revenues of US$1,489 million and profit attributable to shareholders of US$299 million.
Latest Hikma Pharmaceuticals News & Features
26 September 2023
9 February 2023
12 January 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze